ebomi
Colour theme
Sign in
Insider · CIK 0001280265

Alta Biopharma Partners III GMBH & Co Beteiligungs KG

CIK 0001280265 Name as filed on the most recent filing

Filed as Alta Biopharma Partners III GMBH & Co Beteiligungs KG (12)

47 transaction lines · from 12 filings · filed 2004-10-19 to 2014-02-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-02-05 P, Open-market purchase Cara Therapeutics, Inc.CARA 3 lines 1,240,987, acquired Open Form 4 filing 0001209191-14-007595
2012-10-16 S, Open-market sale Aegerion Pharmaceuticals, Inc.AEGR 3 lines 2,613,800, disposed Open Form 4 filing 0001209191-12-049852
2012-10-15 S, Open-market sale Aegerion Pharmaceuticals, Inc.AEGR 3 lines 1,065,257, disposed Open Form 4 filing 0001209191-12-049852
2011-08-09 P, Open-market purchase Aegerion Pharmaceuticals, Inc.AEGR 3 lines 68,497, acquired Open Form 4 filing 0001209191-11-043220
2011-08-08 P, Open-market purchase Aegerion Pharmaceuticals, Inc.AEGR 3 lines 52,204, acquired Open Form 4 filing 0001209191-11-043220
2010-10-27 P, Open-market purchase Aegerion Pharmaceuticals, Inc.AEGR 3 lines 2,999,996, acquired Open Form 4 filing 0001209191-10-051904
2010-06-30 P, Open-market purchase Sunesis Pharmaceuticals IncSNSS 3 lines 3,275,862, acquired Open Form 4 filing 0001209191-10-036944
2009-12-14 S, Open-market sale Sunesis Pharmaceuticals IncSNSS 3 lines 4,485,913, disposed Open Form 4 filing 0001209191-09-057467
2009-10-05 P, Open-market purchase Threshold Pharmaceuticals IncTHLD 3 lines 500,000, acquired Open Form 4 filing 0001209191-09-047812
2009-09-08 S, Open-market sale TorreyPines Therapeutics, Inc.TPTX 6 lines 92,689, disposed Open Form 4 filing 0001209191-09-043545
2009-09-03 S, Open-market sale TorreyPines Therapeutics, Inc.TPTX 6 lines 68,777, disposed Open Form 4 filing 0001209191-09-043545
2005-10-14 S, Open-market sale Cotherix IncCTRX 3 lines 2,170,181, disposed Open Form 4 filing 0001209191-05-052708
2005-10-12 S, Open-market sale Cotherix IncCTRX 3 lines 3,215,082, disposed Open Form 4 filing 0001209191-05-052402
2004-10-15 P, Open-market purchase Cotherix IncCTRX 2,150,556, acquired Open Form 4 filing 0001209191-04-049151
2004-10-15 P, Open-market purchase Cotherix IncCTRX 2,499,996, acquired Open Form 4 filing 0001209191-04-048864

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001280265

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.